| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tafasitamab | b-lymphocyte antigen cd19 | biotech | NA | drugbank | Relapse[MeSHID:D012008] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Chronic Lymphocytic Leukemia[MeSHID:D015451] |
NA | approved,investigational | binder,antibody |
| click here to return to the previous page | ||||||||